Elkem (OB:ELK) Stock Faces Q2 Loss As Weak Margins Test Bullish Growth Narrative

Elkem (OB:ELK) has just reported Q2 2026 revenue of NOK 3,707 million with basic EPS of NOK 0.20 loss per share, setting a cautious tone for the quarter. The company has seen quarterly revenue move from NOK 4,301 million in Q2 2025 to NOK 3,707 million in Q2 2026, while basic EPS shifted from a NOK 0.17 loss per share to a NOK 0.20 loss. Trailing 12 month EPS now sits at NOK 0.73 on revenue of NOK 15,378 million. For investors, the key storyline out of these results is how compressed margins and weaker recent profitability compare with the stronger growth outlook that many are watching.

See our full analysis for Elkem.

With the headline numbers set, the next step is to see how Elkem’s latest revenue, EPS and margin trends line up against the prevailing market and community narratives around the stock.

See what the community is saying about Elkem

Loss of NOK 88 million from ongoing operations

• Elkem reported net income from continuing operations of NOK 88 million loss in Q2 2026, compared with NOK 165 million profit in Q1 2026 and NOK 105 million loss in Q2 2025.
• Bulls point to forecasts of roughly 69% yearly earnings growth, yet the move from NOK 165 million profit to a NOK 88 million loss in just one quarter tests that optimism, as:
  • Trailing 12 month net profit margin is 2.8%, lower than the 4.1% level a year ago, so recent profitability is already thinner than in the past year.
  • Discontinued operations reduced earnings by NOK 680 million in Q2 2026, a larger drag than the NOK 138 million effect seen in Q1 2026, which makes the path to those higher earnings less straightforward than the bullish narrative suggests.

For a deeper look at how optimistic investors frame these swings in profitability, check out the 🐂 Elkem Bull Case.

Interest coverage risk against weak margins

• Over the last 12 months, Elkem generated NOK 430 million in net income from continuing operations on NOK 15,378 million of revenue, which equates to a 2.8% net margin compared with 4.1% a year earlier, at a time when interest payments are flagged as not well covered by earnings.
• Bears focus on that thinner 2.8% margin and weak interest coverage as a pressure point, and the Q2 2026 loss from ongoing operations adds weight to that view because:
  • Quarterly net income from continuing operations has swung between NOK 218 million profit (Q3 2025) and NOK 88 million loss (Q2 2026), which leaves less room to handle finance costs consistently.
  • Over the trailing 12 months, discontinued operations reduced earnings by NOK 1,319 million, so any ongoing leverage or refinancing needs sit on top of already modest profit from the core business.

If you want to see how cautious investors frame these margin and debt concerns in more detail, have a look at the 🐻 Elkem Bear Case.

Mixed signals from Elkem valuation

• At a share price of NOK 30.30, Elkem trades on a trailing P/E of 25.5x, higher than both the 14.9x peer average and the 19x European Chemicals sector, while the DCF fair value in this dataset sits at NOK 90.48 per share.
• Consensus narrative highlights expected revenue growth of roughly 8.4% per year and strong forecast earnings growth, yet current results introduce tension with that balanced view because:
  • Trailing 12 month revenue of NOK 15,378 million is lower than the NOK 17,458 million level a year earlier, and net income from continuing operations over the same period is NOK 430 million versus NOK 2,123 million a year ago, which contrasts with the stronger growth assumptions.
  • The higher P/E multiple and lower 2.8% margin sit alongside a DCF fair value of NOK 90.48, so investors are weighing weaker recent profitability against a model that suggests the current price is materially below that estimate.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Elkem on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Given the mix of pressure points and brighter spots around Elkem, it makes sense to move quickly from headlines to the underlying data and form your own view, starting with the 2 key rewards and 2 important warning signs.

See What Else Is Out There

Elkem is currently working through thinner 2.8% margins, a recent loss from ongoing operations and interest costs that earnings do not comfortably cover.

If you are concerned about those margin swings and earnings pressure, it is worth urgently checking 297 resilient stocks with low risk scores to focus on companies with more resilient financial profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com